. Author manuscript; available in PMC: 2016 Mar 24.

Published in final edited form as: Int J Neuropsychopharmacol. 2011 Apr 28;15(4):509–521. doi: 10.1017/S1461145711000630

Table 4.

Effects of adrenergic drugs on Nur77 expression in extra-striatal areas

	Veh	Prazosin	Idazoxan	Haloperidol	Prazosin+Hal	Idazoxan+Hal
Nur77 mRNA levels (% of vehicle)
mPFC	100±14	73±4	151±10	116±9	131±9	150±18
CC	100±16	62±16	125±16	109±11	124±8	148±9
NAcS	100±12	41±20^*	77±14	221±11^***	216±4^***	304±10^***^##
NAcC	100±1	38±4^**	96±5	250±9^***	197±6^***^##	263±6^***
SNc	100±23	132±35	141±20	772±80^***	827±93^***	1094±119^***^#
VTA	100±18	113±18	104±11	475±60^***	707±69^***^#	618±55^***

CC, Cingulate cortex ; Hal, haloperidol; mPFC, medial prefrontal cortex ; NAcC, nucleus accumbens core ; NAcS, nucleus accumbens shell ; SNc, substantia nigra pars compacta; VTA, ventral tegmental area ; Veh, vehicle.

Values represent mean±S.E.M. from five animals per group

p<0.05,

^**

p<0.01,

^***

p<0.001 vs. Veh group;

p<0.05,

^##

p<0.01 vs. haloperidol group.